AI Powered Mapping Technology for Identifying Arrhythmias
Completed
Conditions studied: Arrhythmias, Cardiac
In brief
Exploratory, hypothesis-generating study evaluating the impact of vMap on procedural efficiency, acute success, and work flow optimization.
Key facts
- Study ID
- NCT06939478
- Run by
- Heart Rhythm Clinical and Research Solutions, LLC
- People needed
- 112
- Starts
- 2025-08-27
- Expected to finish
- 2026-05-15
- Last updated by the study team
- 2026-05-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients who had a standard of care cardiac ablation (de novo or repeat) where the vMap equipment was used.
- The patient can provide written informed consent, if applicable.
- The patient is greater than or equal to 18 years old
- Prospective Arm:
- Inclusion Criteria:
- Patients who had a standard of care cardiac ablation (de novo or repeat) where the vMap equipment was used.
- The patient can provide written informed consent, if applicable.
- The patient is greater than or equal to 18 years old
You may not qualify if…
- Participants who meet any one of the following criteria will be a screen failure and excluded from participation:
- Non-inducible arrhythmia (unless pre-mapped via vMap prior to the procedure).
- Patients in whom no ablation was performed using the vMap equipment.
- Inability to obtain 12-lead ECG of sufficient quality for vMap analysis.
- In the opinion of the Investigator, the participant is not suitable and has a contraindication to undergo the ablation procedure.
Where it is running
- Grandview Medical Center — Birmingham, Alabama, United States
- Ascension St. Vincent's — Jacksonville, Florida, United States
- HCA Florida Healthcare — Miami, Florida, United States
- OhioHealth — Columbus, Ohio, United States
- Penn Presbyterian Medical Center — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.